Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6959)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2014 (publication date) through May 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i38/13718.htm |
| Number | Citing Articles |
| 1 |
Yasuo Uno, Mitsuro Kanda, Takashi Miwa, Shinichi Umeda, Haruyoshi Tanaka, Chie Tanaka, Daisuke Kobayashi, Masaya Suenaga, Norifumi Hattori, Masamichi Hayashi, Suguru Yamada, Goro Nakayama, Michitaka Fujiwara, Yasuhiro Kodera. Increased Expression of DNAJC12 is Associated with Aggressive Phenotype of Gastric Cancer. Annals of Surgical Oncology 2019; 26(3): 836 doi: 10.1245/s10434-018-07149-y
|
| 2 |
Md. Rezaul Islam, Abdur Rauf, Shopnil Akash, Ajoy Kumer, Md Sadique Hussain, Smrity Akter, Jeetendra Kumar Gupta, L.H. Thameemul Ansari, Mir Md. Mahfoj Islam Raj, Talha Bin Emran, Abdullah S.M. Aljohani, Waleed Al Abdulmonem, Rekha Thiruvengadam, Muthu Thiruvengadam. Recent perspective on the potential role of phytocompounds in the prevention of gastric cancer. Process Biochemistry 2023; 135: 83 doi: 10.1016/j.procbio.2023.11.006
|
| 3 |
Chen-Wei Chiang, Yun-Shih Lin, Fu-Ling Chang, Tsai-Yu Lin, Keng-Chang Tsai, Wei-Chun HuangFu, Yu-Ching Lee. Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer. Biochemical and Biophysical Research Communications 2023; 680: 161 doi: 10.1016/j.bbrc.2023.09.025
|
| 4 |
HUI LIU, SHAOHUA LIANG, XI YANG, ZHAONING JI, WENYING ZHAO, XIAOBING YE, JING RUI. RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells. Oncology Reports 2015; 34(5): 2267 doi: 10.3892/or.2015.4219
|
| 5 |
PrameelaG Chelakkot, Rahul Ravind, K Sruthi, Durgapoorna Menon. Treatment in resectable non-metastatic adenocarcinoma of stomach: Changing paradigms. Indian Journal of Cancer 2019; 56(1): 74 doi: 10.4103/ijc.IJC_375_18
|
| 6 |
Hayato Baba, Mitsuro Kanda, Koichi Sawaki, Shinichi Umeda, Takashi Miwa, Dai Shimizu, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Yasuhiro Kodera, Tsutomu Fujii. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer. Annals of Surgical Oncology 2020; 27(6): 2071 doi: 10.1245/s10434-019-07985-6
|
| 7 |
Shahab Bohlooli, Shahriar Bohlooli, Roghaye Aslanian, Fatemeh Nouri, Ali Teimourzadeh. Aqueous extract of Agrostemma githago seed inhibits caspase-3 and induces cell-cycle arrest at G1 phase in AGS cell line. Journal of Ethnopharmacology 2015; 175: 295 doi: 10.1016/j.jep.2015.07.010
|
| 8 |
Mitsuro Kanda, Yasuhiro Kodera, Junichi Sakamoto. Updated evidence on adjuvant treatments for gastric cancer. Expert Review of Gastroenterology & Hepatology 2015; 9(12): 1549 doi: 10.1586/17474124.2015.1094373
|
| 9 |
Shogo Hayashi, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer 2019; 22(4): 853 doi: 10.1007/s10120-018-0902-2
|
| 10 |
Karol Rawicz-Pruszyński, Bogumiła Ciseł, Radosław Mlak, Jerzy Mielko, Magdalena Skórzewska, Magdalena Kwietniewska, Agnieszka Pikuła, Katarzyna Gęca, Katarzyna Sędłak, Andrzej Kurylcio, Wojciech P. Polkowski. The Role of the Lymph Node Ratio in Advanced Gastric Cancer After Neoadjuvant Chemotherapy. Cancers 2019; 11(12): 1914 doi: 10.3390/cancers11121914
|
| 11 |
Reza Shamsabadi, Hamed Bagheri, Ebrahim Hazrati, Mojtaba Yousefi Zoshk, Seyed Rabi Mahdavi, Mohsen Askari, Masoumeh Sajadi Rad. Secondary cancer risk estimations following the gastric cancer radiotherapy. The European Physical Journal Plus 2023; 138(1) doi: 10.1140/epjp/s13360-023-03694-y
|
| 12 |
Mozaffar Aznab, Omid Beiki, Kiumars Eslam pia, Khosro Setayeshi, Mohamad Ali Hesami, Houshang Vrae. Evaluation the Survival of Patients with Gastric Cancer Treated with Adjuvant or Palliative Chemotherapy. Journal of Gastrointestinal Cancer 2017; 48(1): 31 doi: 10.1007/s12029-016-9868-7
|
| 13 |
Wei‐Chun Chang, Wei‐Chung Cheng, Bi‐Hua Cheng, Lumin Chen, Li‐Jing Ju, Yu‐Jer Ou, Long‐Bin Jeng, Mei‐Due Yang, Yao‐Ching Hung, Wen‐Lung Ma. Mitochondrial Acetyl‐CoA Synthetase 3 is Biosignature of Gastric Cancer Progression. Cancer Medicine 2018; 7(4): 1240 doi: 10.1002/cam4.1295
|
| 14 |
Krishna Kotecha, Animesh Singla, Philip Townend, Neil Merrett. Association between neutrophil-lymphocyte ratio and lymph node metastasis in gastric cancer. Medicine 2022; 101(25): e29300 doi: 10.1097/MD.0000000000029300
|
| 15 |
Xuefen Lei, Feng Wang, Yang Ke, Dong Wei, Hou Gu, Zhixian Zhang, Lifeng Jiang, Li Lv, Jie Lin, Lin Wang. The role of antiangiogenic agents in the treatment of gastric cancer. Medicine 2017; 96(10): e6301 doi: 10.1097/MD.0000000000006301
|
| 16 |
Jin Cheng, Jing Wu, Yingjiang Ye, Chunfang Zhang, Yinli Zhang, Yi Wang. The prognostic significance of extramural venous invasion detected by multiple-row detector computed tomography in stage III gastric cancer. Abdominal Radiology 2016; 41(7): 1219 doi: 10.1007/s00261-015-0627-1
|
| 17 |
Maria C. Russell. Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer. Journal of Surgical Oncology 2016; 114(3): 296 doi: 10.1002/jso.24293
|
| 18 |
Xiangdong Cheng, Yi Lu. A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese population. Future Oncology 2018; 14(8): 771 doi: 10.2217/fon-2017-0558
|
| 19 |
Jin Cheng, Caizhen Feng, Yinli Zhang, Nan Hong, Yingjiang Ye, Yi Wang. CT-Detected Extramural Vessel Invasion and Regional Lymph Node Involvement in Stage T4a Gastric Cancer for Predicting Progression-Free Survival. American Journal of Roentgenology 2019; 212(5): 1030 doi: 10.2214/AJR.18.20342
|
| 20 |
Fatemeh Karami, Ahmad Dourandish Yazdi, Iman Salahshourifar, Mohsen Marvi Beigi. Investigating the Effects of Salvia chorassanica Bunge and Shoot Extracts on Gastric Cancer Cells: Evidence of Different Behavior on Various Tumor Grades. Pharmaceutical Sciences 2020; 27(3): 378 doi: 10.34172/PS.2020.99
|
| 21 |
LIANCHENG LIU, ZHIGANG BAI, XUEMEI MA, TINGTING WANG, YAO YANG, ZHONGTAO ZHANG. Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin. Experimental and Therapeutic Medicine 2016; 11(3): 846 doi: 10.3892/etm.2016.2994
|
| 22 |
Sung Ho Jang, Young Jae Jung, Min Gyu Kim, Sung Joon Kwon. The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study. Journal of Gastric Cancer 2018; 18(1): 48 doi: 10.5230/jgc.2018.18.e4
|
| 23 |
Wei-Chun Chang, Shang-Fen Huang, Yang-Ming Lee, Hsueh-Chou Lai, Bi-Hua Cheng, Wei-Chung Cheng, Jason Yen-Ping Ho, Long-Bin Jeng, Wen-Lung Ma. Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival. Oncotarget 2017; 8(1): 692 doi: 10.18632/oncotarget.13524
|
| 24 |
Sebastián Mondaca, Mauricio P. Pinto, Juan Briones, Nicole Caire, José Peña, Érica Koch, Sabrina Muñiz, María Elisa Herrera, Cesar Sánchez, Héctor Galindo, Gonzalo Pizarro, Francisco Acevedo, Carolina Ibañez, Carlos Balmaceda, Enrique Norero, Doris Duran, Marcelo Garrido, Bruno Nervi. Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study. Value in Health Regional Issues 2023; 35: 13 doi: 10.1016/j.vhri.2022.12.005
|
| 25 |
C. Roderburg, C. Trautwein. Onkologische Therapie des Ösophagus- und Magenkarzinoms. Der Gastroenterologe 2017; 12(5): 407 doi: 10.1007/s11377-017-0188-7
|
| 26 |
Maria Vassilakopoulou, Kazuto Harada, Jaffer A Ajani. Ramucirumab for the treatment of gastric adenocarcinoma. Expert Opinion on Orphan Drugs 2018; 6(8): 449 doi: 10.1080/21678707.2018.1500689
|
| 27 |
Zhiying Zhang, Jidong Peng. Clinical nursing and postoperative prediction of gastrointestinal cancer based on CT deep learning model. Journal of Radiation Research and Applied Sciences 2023; 16(2): 100561 doi: 10.1016/j.jrras.2023.100561
|
| 28 |
Nozomu Fuse, Hideaki Bando, Keisho Chin, Seiji Ito, Takaki Yoshikawa, Akira Tsuburaya, Masanori Terashima, Yoshiyuki Kawashima, Tetsu Fukunaga, Masahiro Gotoh, Yasunori Emi, Kazuhiro Yoshida, Eiji Oki, Seiji Takahashi, Hiroshi Kuriki, Kumi Sato, Mitsuru Sasako. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer 2017; 20(2): 332 doi: 10.1007/s10120-016-0606-4
|
| 29 |
Yu Kyung Lee, Kyeore Bae, Hwa-Seung Yoo, Seung-Hun Cho. Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer. Integrative Cancer Therapies 2018; 17(3): 619 doi: 10.1177/1534735417753542
|
| 30 |
Daguang Wang, Yabin Sun, Wei Li, Fei Ye, Yang Zhang, Yuchen Guo, David Zhang, Jian Suo. Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3460
|
| 31 |
Zhaoyan Li, Guangtao Zhang, Nida Cao, Jingjuan Xu, Jiahuan Dong, Jia Li, Xiaohong Zhu, Yan Xu, Chen Han, Rui Wang, Xiang Xia, Gang Zhao, Xiangkun Huan, Jin Fan, Aiguang Zhao. Effects of traditional Chinese medicine collaborative model (TCMCM) combined with adjuvant chemotherapy on IIIb and IIIc gastric cancer: a protocol for a randomized controlled trial. Trials 2022; 23(1) doi: 10.1186/s13063-022-06013-5
|